These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2979114)

  • 21. Malignant hyperthermia following preoperative oral administration of dantrolene.
    Fitzgibbons DC
    Anesthesiology; 1981 Jan; 54(1):73-5. PubMed ID: 7457985
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.
    Watson CB; Reierson N; Norfleet EA
    Anesthesiology; 1986 Sep; 65(3):312-4. PubMed ID: 3752576
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dantrolene and malignant hyperthermia].
    Grote B
    Anaesthesist; 1982 May; 31(5):211-2. PubMed ID: 7103028
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiopulmonary bypass in the treatment of malignant hyperthermia].
    Kotsuka Y; Furuse A; Teruya M; Asano K
    Kyobu Geka; 1984 Apr; 37(4):286-91. PubMed ID: 6748410
    [No Abstract]   [Full Text] [Related]  

  • 25. Sevoflurane-induced malignant hyperthermia during cardiopulmonary bypass and moderate hypothermia.
    Jonassen AA; Petersen AJ; Mohr S; Andersson C; Skattum J; Kvernebo K; Paulsen OG; Stokland O; Kirkebøen KA
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1062-5. PubMed ID: 15315628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous dantrolene in a patient with myasthenia gravis.
    Mora CT; Eisenkraft JB; Papatestas AE
    Anesthesiology; 1986 Mar; 64(3):371-3. PubMed ID: 3954134
    [No Abstract]   [Full Text] [Related]  

  • 27. [Malignant hyperthermia. Immediate treatment and procedure in another anesthesia].
    Schuh FT
    Dtsch Med Wochenschr; 1981 Oct; 106(43):1431-2. PubMed ID: 7285828
    [No Abstract]   [Full Text] [Related]  

  • 28. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
    Bernhardt D
    Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of ryanodine toxicity by dantrolene and halothane in a model of malignant hyperthermia.
    Fairhurst AS; Hamamoto V; Macri J
    Anesthesiology; 1980 Sep; 53(3):199-204. PubMed ID: 7425333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ECT use for a patient with malignant hyperthermia.
    Franks RD; Aoueille B; Mahowald MC; Masson N
    Am J Psychiatry; 1982 Aug; 139(8):1065-6. PubMed ID: 7091436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
    Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
    J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hyperthermia. Dantrolene--dynamics and kinetics.
    Harrison GG
    Br J Anaesth; 1988 Feb; 60(3):279-86. PubMed ID: 3279988
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
    Ruhland G; Hinkle AJ
    Anesthesiology; 1984 Feb; 60(2):159-60. PubMed ID: 6696240
    [No Abstract]   [Full Text] [Related]  

  • 34. Dantrolene in porcine malignant hyperthermia.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant hyperthermia in an office surgery suite: a case report.
    Turpin IM; Manino J
    Aesthetic Plast Surg; 1989; 13(2):121-3. PubMed ID: 2741752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of an unsuspected case of malignant hyperpyrexia.
    Thiagarajah S
    Middle East J Anaesthesiol; 1986 Feb; 8(4):269-75. PubMed ID: 3960004
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
    Blank JW; Boggs SD
    J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated nonanesthetic malignant hyperthermia reactions in a child.
    Cummings T; Der T; Karsli C
    Paediatr Anaesth; 2016 Dec; 26(12):1202-1203. PubMed ID: 27562486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Almost-certain malignant hyperthermia during cardiopulmonary bypass: a case report and literature review.
    Zhang Y; Zhou R
    Perfusion; 2019 Sep; 34(6):490-494. PubMed ID: 30843472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.